ZDF
Sign inSign up

Vulnerabilities

Security fix · CVE-2025-9735

A weakness has been identified in O2OA up to 10.0-410.

Published Aug 31, 2025 · catalog updated Oct 19, 2026 · O2OA

Check this week

CVE-2025-9735 is not in CISA KEV. FIRST estimates a 27.00% chance of exploitation in the next 30 days. Check whether you run O2OA.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
27.00%
Remediation
Advisory link
Affected products
cpe zoneland/o2oa · vendor n/a O2OA 10.0-410

A weakness has been identified in O2OA up to 10.0-410. This affects an unknown function of the file /x_query_assemble_designer/jaxrs/table of the component Personal Profile Page. This manipulation of the argument description/applicationName/queryName causes cross site scripting. The attack may be initiated remotely. The exploit has been made available to the public and could be exploited. The vendor replied in the GitHub issue (translated from simplified Chinese): "This issue will be fixed in the new version."

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe zoneland/o2oaversion unspecified
  • vendor n/a O2OA 10.0-41010.0-410

How to fix CVE-2025-9735

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-9735 is not in CISA KEV. FIRST estimates a 27.00% chance of exploitation in the next 30 days. Check whether you run O2OA.

Which versions are affected?

Compare what you have installed with n/a O2OA 10.0-410 10.0-410. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS); CWE-94: Code Injection. EPSS 27.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Aug 31, 2025 · NIST NVD

    Detected

    A weakness has been identified in O2OA up to 10.0-410. This affects an unknown function of the file /x_query_assemble_designer/jaxrs/table of the component Personal Profile Page. This manipulation of the argument description/applicationName/queryName causes cross site scripting. The attack may be initiated remotely. The exploit has been made available to the public and could be exploited. The vend

  2. Oct 19, 2026 · NIST NVD

    Updated

    A weakness has been identified in O2OA up to 10.0-410. This affects an unknown function of the file /x_query_assemble_designer/jaxrs/table of the component Personal Profile Page. This manipulation of the argument description/applicationName/queryName causes cross site scripting. The attack may be initiated remotely. The exploit has been made available to the public and could be exploited. The vend

Sources

  • CVE.orgVulnerability recordCVE-2025-9735

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-26301

    A weakness has been identified in O2OA up to 10.0-410. This affects an unknown function of the file /x_query_assemble_designer/jaxrs/table of the component Personal Profile Page. This manipulation of the argument description/applicationName/queryName causes cross site scripting.

    euvd.enisa.europa.eu
  • NIST NVDVulnerability recordCVE-2025-9735

    A weakness has been identified in O2OA up to 10.0-410. This affects an unknown function of the file /x_query_assemble_designer/jaxrs/table of the component Personal Profile Page. This manipulation of the argument description/applicationName/queryName causes cross site scripting.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 19, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.